• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

What Can Be Done to Ensure Access to Care for Dual-Eligible Beneficiaries?

News
Podcast

An author of a study in the May 2021 issue of The American Journal of Managed Care® describes how the COVID-19 pandemic, the aging of America, and already-existing workforce shortages will further threaten the dual-eligible population unless policy makers reform scope-of-practice laws.

Triple forces are combining to create a crisis for the nation’s dual-eligible beneficiaries—that is, individuals who are covered under both Medicare and Medicaid. They tend to have multiple, chronic, costly medical conditions and have very low incomes.

In the May issue of The American Journal of Managed Care®, Wendy Y. Xu, PhD; Sheldon M. Retchin, MD, MSPH; and Peter Buerhaus, PhD, RN, published a study showing how states with the most restrictive scope-of-practice laws have an inadequate supply of primary care clinicians to serve areas with a high concentration of these vulnerable beneficiaries.

In this episode of Managed Care Cast, Xu describes how the COVID-19 pandemic, the aging of America, and already-existing workforce shortages will further threaten this population unless policy makers reform scope-of-practice laws.

Listen above or through one of these podcast services:

iTunes
TuneIn
Stitcher
Spotify

Related Videos
Phaedra Corso, PhD, associate vice president for research at Indiana University
Julie Patterson, PharmD, PhD
William Padula, PhD, MSc, MS, assistant professor of pharmaceutical and health economics, University of California Alfred E. Mann School of Pharmacy and Pharmaceutical Sciences
Dr Chris Pagnani
Nancy Dreyer, MPH, PhD, FISE, chief scientific advisor to Picnic Health
Screenshot of Mary Dunn, MSN, NP-C, OCN, RN, during a video interview
Seth Berkowitz, MD, MPH, associate professor of medicine, University of North Carolina at Chapel Hill
Inma Hernandez, PharmD, PhD, professor at the University of California, San Diego Skaggs School of Pharmacy and Pharmaceutical Sciences
Binod Dhakal, MD
Screenshot of Joshua Meeks, MD, PhD, during a video interview
Related Content
© 2024 MJH Life Sciences
AJMC®
All rights reserved.